Antibody-Drug Conjugates Used in Breast Cancers

被引：8
|
作者：
Abbas, Aram J. [1 ]
Ibrahim, Marah F. [2 ]
Saifo, Maher S. [1 ,2 ]
机构：
[1] Damascus Univ, Fac Med, Damascus, Syria
[2] Alsham Private Univ, Fac Pharm, Damascus, Syria
来源：
JOURNAL OF ONCOLOGY | 2021年 / 2021卷
关键词：
SACITUZUMAB GOVITECAN; MONOCLONAL-ANTIBODY; NEXT-GENERATION; CHALLENGES; STRATEGIES; SELECTION; ISOTYPE; DESIGN; LINKER; ADCS;
D O I：
10.1155/2021/9927433
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The prognosis of breast cancer has radically changed in recent years and continues to improve due to the broad application of effective therapies. New targeting strategies including targeted delivery of cytotoxic drugs via receptor-targeting agents have been developed. We summarize recent publications and developments of novel antibody-drug conjugates (ADCs) used to control breast cancer.
引用
收藏
页数：7
相关论文
共 50 条
  • [21] Antibody-drug conjugates in breast cancer: advances and prospects
    Zhiqiang Shi
    Yongjin Lu
    Qiuchen Zhao
    Yongsheng Wang
    Pengfei Qiu
    Cancer Biology & Medicine, 2025, 22 (02) : 83 - 92
  • [22] Antibody-drug conjugates in elderly patients with breast cancer
    Bonotto, Marta
    De Pieri, Giulia
    Esposto, Rocco
    Lay, Ludovica
    Aprile, Giuseppe
    Puglisi, Fabio
    Minisini, Alessandro Marco
    BREAST, 2025, 80
  • [23] Antibody-drug conjugates in breast cancer: the chemotherapy of the future?
    Nicolo, Eleonora
    Zagami, Paola
    Curigliano, Giuseppe
    CURRENT OPINION IN ONCOLOGY, 2020, 32 (05) : 494 - 502
  • [24] Antibody-drug conjugates in triple negative breast cancer
    Tray, Nancy
    Adams, Sylvia
    Esteva, Francisco J.
    FUTURE ONCOLOGY, 2018, 14 (25) : 2651 - 2661
  • [25] Antibody-drug conjugates in breast cancer: advances and prospects
    Shi, Zhiqiang
    Lu, Yongjin
    Zhao, Qiuchen
    Wang, Yongsheng
    Qiu, Pengfei
    CANCER BIOLOGY & MEDICINE, 2025, 22 (02) : 83 - 92
  • [26] Advances with antibody-drug conjugates in breast cancer treatment
    Subhan, Md Abdus
    Torchilin, Vladimir P.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2021, 169 : 241 - 255
  • [27] Antibody-Drug Conjugates in Breast Cancer: a Comprehensive Review
    Noam Pondé
    Philippe Aftimos
    Martine Piccart
    Current Treatment Options in Oncology, 2019, 20
  • [28] Antibody-Drug Conjugates in Breast Cancer: a Comprehensive Review
    Ponde, Noam
    Aftimos, Philippe
    Piccart, Martine
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (05)
  • [29] Antibody-Drug Conjugates in Triple Negative Breast Cancer
    Keskinkilic, Merve
    Sacks, Ruth
    CLINICAL BREAST CANCER, 2024, 24 (03) : 163 - 174
  • [30] Monoclonal antibody-drug conjugates
    Hamann, PR
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (09) : 1087 - 1103
12345